Biotech | February 22, 2022
Prestige BioPharma’s facility receives EU-GMP certification
The facility will manufacture its Herceptin biosimilar, Tuznue
The facility will manufacture its Herceptin biosimilar, Tuznue
According to the Indian Journal of Medical Research in 2018, the estimated prevalence of pre-diabetes in India is 14%, which means that one out of six Indians is pre-diabetic
Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear
Recall does not include any metabolic deficiency nutrition formulas
Phase 2 clinical trial to begin in 2022 with participation by Cedars Sinai Medical Center, University of Utah, and City of Hope
Evonik invests in start-up to improve patient recovery after open-chest surgery
Darolutamide is developed jointly by Bayer and Orion Corporation
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia
Biosynthetic Technologies produces estolides, a new class of biobased synthetic oils used in a number of applications, including motor oil, industrial lubricants, pharmaceuticals, and personal care.
Subscribe To Our Newsletter & Stay Updated
